Axsome Therapeutics
NasdaqGM:AXSM
$ 178,11
$-0,75 (-0,42%)
178,11 $
$-0,75 (-0,42%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-3,47
Earnings Per Share
$12,48
Revenue Per Share
92,56%
Gross Margin %
$9,15 B
Market Cap
$0,12 B
Long-Term Debt
Earnings Per Share
$-3,47
Revenue Per Share
$12,48
Gross Margin %
92,56%
Market Cap
$9,15 B
Long-Term Debt
$0,12 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share $-3,47 $-5,99 $-5,27 $-4,60 $-3,47 $-2,73 $-2,01 $-1,26 $-1,24 $-1,42 $-0,69
Earnings Earnings $-177,49M $-292,13M $-249,64M $-200,19M $-133,53M $-102,13M $-74,53M $-41,93M $-31,61M $-27,26M $-13,21M
RPS Revenue Per Share $0,00 $12,48 $7,91 $5,71 $1,15 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00
Revenue Revenue $0,00M $638,50M $385,69M $270,60M $50,04M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $-123,03M $-128,41M $-145,08M $-116,51M $-108,23M $-78,46M $-46,38M $-30,05M $-26,47M $-21,28M $-7,44M
FCF Free Cash Flow $0,00M $-105,00M $-128,68M $-160,92M $-117,21M $-108,53M $-78,50M $-46,39M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% -26,51% -65,45% -67,59% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 92,56% 91,37% 90,37% 91,81% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $0,00 $-2,69 $-3,21 $-2,88 $-2,89 $-2,11 $-1,36 $-1,12 $-1,16 $-1,12 $-0,62
LT Debt Long-Term Debt N/A $117,75M $180,71M $178,07M $94,26M $49,09M $48,32M $17,33M $3,62M $6,66M $9,47M N/A
Sha. Stocks 50,88M 51,15M 48,77M 47,37M 43,52M 38,48M 37,41M 37,08M 33,28M 25,49M 19,2M 19,15M
×